KBU2046
KBU2046 is an orally bioavailable small molecule that uniquely targets chaperone heterocomplexes to modulate client protein interactions, thereby inhibiting cell motility and invasion. This mechanism suppresses metastasis in preclinical models, extending lifespan without the typical profile of classical HSP90 inhibitors, making it a valuable tool for cancer metastasis research.
Product Specifications
CAS Number
1143863-69-7
Product Name Alternative
Inhibitor, KBU 2046, KBU2046, KBU-2046, inhibit
Field of Research
Metabolism Research, Signal Transduction
Purity
99.87% (May vary between batches)
Solubility
DMSO:45 mg/mL (185.77 mM)
Smiles
Fc1ccc (cc1) C1COc2ccccc2C1=O
Molecular Formula
C15H11FO2
Molecular Weight
242.24
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR10407803 96 Well
Chicken Kappa immunoglobulin light chain ELISA kit
Sign In for Pricing
View Details 
NBP3-28148-1mg 1 mg
CHO Monoclonal CD19 Antibody (Duke U. patent anti-CD19) - Humanized - (Dry Ice)
Sign In for Pricing
View Details RK11389 96 Tests
Human Multidrug resistance-associated protein 6 (ABCC6) ELISA Kit
Sign In for Pricing
View Details 
LY401102 100 µg
Synaptophysin (SYP) (NM_003179) Human Over-expression Lysate
Sign In for Pricing
View Details 